Ploiesti

Romania

51 total trials 25 recruiting

Filter these 51 trials by phase, condition, sponsor and more.

Open in Search →

A study of MK7684A versus Pembrolizumab in PD-L1 Positive Metastatic NSCLC (KEYVIBE-003) Ended

2023-505362-28-00 5 2021-04-21 Stage IV non small-cell lung cancer
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV … Ended

2023-507846-96-00 5 2020-06-19 Type 2 Diabetes Mellitus
Phase 3 study of SBRT ± pembrolizumab for participants with unresectable Stage I or II NSCLC Ended

2022-500413-11-00 5 2019-06-17 Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC)

Showing 49–51 of 51 trials